UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abuse liability and reinforcing efficacy of oral tramadol in humans

Drug and alcohol dependence, 2013-04, Vol.129 (1), p.116-124

2013

Volltextzugriff (PDF)

Recent Increase in Methamphetamine Use in a Cohort of Rural People Who Use Drugs: Further Evidence for the Emergence of Twin Epidemics

Frontiers in psychiatry, 2022-01, Vol.12, p.805002-805002

2022

Volltextzugriff (PDF)

Putting Parity into Practice — Integrating Opioid-Use Disorder Treatment into the Hospital Setting

The New England journal of medicine, 2016-09, Vol.375 (9), p.811-813

2016

Volltextzugriff (PDF)

State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements

Drug and alcohol dependence reports, 2023-06, Vol.7, p.100164, Article 100164

2023

Volltextzugriff (PDF)

Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: A two-phase randomized controlled trial

Drug and alcohol dependence, 2013-11, Vol.133 (1), p.188-197

2013

Volltextzugriff (PDF)

The development of a recovery coaching training curriculum to facilitate linkage to and increase retention on medications for opioid use disorder

Frontiers in public health, 2024-02, Vol.12, p.1334850-1334850

2024

Volltextzugriff (PDF)

Effects of short-term oxycodone maintenance on experimental pain responses in physically dependent opioid abusers

The journal of pain, 2017-07, Vol.18 (7), p.825-834

2017

Volltextzugriff (PDF)

A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world

Journal of addiction medicine, 2014-09, Vol.8 (5), p.315-326

2014

Volltextzugriff (PDF)

Long-acting buprenorphine injectables: Opportunity to improve opioid use disorder treatment among rural populations

Preventive medicine, 2021-11, Vol.152, p.106756, Article 106756

2021

Volltextzugriff (PDF)

The changing landscape of naloxone availability in the United States, 2011 – 2017

Drug and alcohol dependence, 2018-10, Vol.191, p.361-364

2018

Volltextzugriff (PDF)

Pharmacodynamic profile of tramadol in humans: influence of naltrexone pretreatment

Psychopharmacologia, 2012-10, Vol.223 (4), p.427-438

2012

Volltextzugriff (PDF)

The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses

Drug and alcohol dependence reports, 2023-03, Vol.6, p.100126, Article 100126

2023

Volltextzugriff (PDF)

Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial

JAMA internal medicine, 2018-06, Vol.178 (6), p.764

2018

Volltextzugriff (PDF)

Facilitating factors and barriers for use of medications to treat opioid use disorder (MOUD) among justice-involved individuals in rural Appalachia

Journal of community psychology, 2023-03

2023

Volltextzugriff (PDF)

Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting Formulations

Journal of addiction medicine, 2019-03, Vol.13 (2), p.93-103

2019

Volltextzugriff (PDF)

Outpatient Parenteral Antimicrobial Therapy Plus Buprenorphine for Opioid Use Disorder and Severe Injection-related Infections

Clinical infectious diseases, 2020-03, Vol.70 (6), p.1226-1229

2020

Volltextzugriff (PDF)

Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers

Drug and alcohol dependence, 2017-03, Vol.172, p.9-13

2017

Volltextzugriff (PDF)

Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis

Neuropsychopharmacology (New York, N.Y.), 2016-07, Vol.41 (8), p.1974-1982

2016

Volltextzugriff (PDF)

Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections

Therapeutic advances in infectious disease, 2022, Vol.9, p.204993612211080

2022

Volltextzugriff (PDF)

Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers

Drug and alcohol dependence, 2010-10, Vol.111 (3), p.265-268

2010

Volltextzugriff (PDF)

Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2016-07, Vol.316 (3), p.282

2016

Volltextzugriff (PDF)

Abuse and Diversion of Gabapentin Among Nonmedical Prescription Opioid Users in Appalachian Kentucky

The American journal of psychiatry, 2015-05, Vol.172 (5), p.487-488

2015

Volltextzugriff (PDF)

Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine

Drug and alcohol dependence, 2012-12, Vol.126 (3), p.379-383

2012

Volltextzugriff (PDF)

Efficacy of continuing medical education to reduce the risk of buprenorphine diversion

Journal of substance abuse treatment, 2011-10, Vol.41 (3), p.321-329

2011

Volltextzugriff (PDF)

Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users

American journal of public health (1971), 2013-01, Vol.103 (1), p.e44-e52

2013

Volltextzugriff (PDF)

1 – 25 von 132

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(112)

Publikationsform

Sprache

Englisch
(132)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(99)
Science & Technology
(99)
Humans
(81)
Psychiatry
(62)
Substance Abuse
(55)
Female
(53)
Adult
(51)
Male
(51)
Opioid-Related Disorders - Drug Therapy
(34)
Double-Blind Method
(31)
Middle Aged
(30)
Narcotics
(30)
Buprenorphine
(28)
Drug Abuse
(26)
Opioids
(26)
Drug Addiction
(25)
Buprenorphine - Therapeutic Use
(19)
Young Adult
(18)
Adolescent
(16)
Analgesics
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Abuse liability and reinforcing efficacy of oral tramadol in humans

Recent Increase in Methamphetamine Use in a Cohort of Rural People Who Use Drugs: Further Evidence for the Emergence of Twin Epidemics

Putting Parity into Practice — Integrating Opioid-Use Disorder Treatment into the Hospital Setting

State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements

Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: A two-phase randomized controlled trial

The development of a recovery coaching training curriculum to facilitate linkage to and increase retention on medications for opioid use disorder

Effects of short-term oxycodone maintenance on experimental pain responses in physically dependent opioid abusers

A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world

Long-acting buprenorphine injectables: Opportunity to improve opioid use disorder treatment among rural populations

The changing landscape of naloxone availability in the United States, 2011 – 2017

Pharmacodynamic profile of tramadol in humans: influence of naltrexone pretreatment

The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses

Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial

Facilitating factors and barriers for use of medications to treat opioid use disorder (MOUD) among justice-involved individuals in rural Appalachia

Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting Formulations

Outpatient Parenteral Antimicrobial Therapy Plus Buprenorphine for Opioid Use Disorder and Severe Injection-related Infections

Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers

Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis

Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections

Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers

Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine: A Randomized Clinical Trial

Abuse and Diversion of Gabapentin Among Nonmedical Prescription Opioid Users in Appalachian Kentucky

Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine

Efficacy of continuing medical education to reduce the risk of buprenorphine diversion

Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users

Suchergebnisse filtern